Clinical Impact of Glucagon-Like Peptide-1 Receptor Analogs on the Complications of Obesity

Abstract Background: Obesity is a chronic disease associated with increased morbidity and mortality due to its complications. The aims of obesity treatment are primarily to accomplish weight loss, and prevention or treatment of its complications. Lifestyle changes along with behavioral therapy const...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Obesity Facts 2023-03, Vol.16 (2), p.149-163
Hauptverfasser:	Yazıcı, Dilek, Yapıcı Eser, Hale, Kıyıcı, Sinem, Sancak, Seda, Sezer, Havva, Uygur, Melin, Yumuk, Volkan
Format:	Artikel
Sprache:	eng
Schlagworte:	Antihypertensives Appetite depressants Body mass index Clinical trials Complications and side effects Diabetes Diabetes Mellitus, Type 2 - complications Disease prevention Dosage and administration Drug dosages Drug therapy Fatty acids Female GLP-1 receptor agonists Glucagon Glucagon-Like Peptide 1 Glucagon-Like Peptide-1 Receptor Glucose Health aspects Hemodynamics Humans Hypertension Hypoglycemic agents Hypoglycemic Agents - therapeutic use Insulin resistance Liver diseases Non-alcoholic Fatty Liver Disease - complications Obesity Obesity - complications Obesity - drug therapy Obesity - metabolism Overweight Oxidation Pathophysiology Peptides Review Review Article Weight control Weight Loss
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!